Skip to main content
. 2020 Jul 14;10:11599. doi: 10.1038/s41598-020-68398-0

Figure 1.

Figure 1

Biomarker levels in Control (n = 18) and AKI (n = 85) patients. *p < 0.05; **p < 0.01; ***p < 0.001 versus “Control” group. AU, arbitrary units; Cru, urinary creatinine; FABP1: fatty acid binding protein 1; GM2AP, GM2-activator protein; KIM-1, kidney injury molecule 1; NAG, N-acetyl-β-d-glucosaminidase; NGAL, neutrophil gelatinase-associated lipocalin; REG3A, regenerating islet-derived 3 alpha; SD, Standard deviation; TCP1-eta, T-complex protein 1 eta.